1-1 of 1
Kerstin M Kampa-Schittenhelm, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

AC220, a Potent Second Generation Class I/III Tyrosine Kinase Inhibitor, Displays a Distinct Inhibition Profile on Mutant-FLT3 as Well as -KIT Isoforms

Kerstin M Kampa-Schittenhelm, MD, Mohit Trikha, Richard F. Schlenk, MD, Hartmut Doehner, MD, Konstanze Doehner, MD, Michael C. Heinrich, MD, Marcus Schittenhelm, MD
Journal: Blood
Blood (2010) 116 (21): 291.
https://doi.org/10.1182/blood.V116.21.291.291
Published: 2010